In a new study researchers found that people receiving Wegovy (semaglutide) lost an average of 10% of their body weight after four years. An earlier analysis of data from this trial found that semaglutide reduced the risk of heart attack, stroke and cardiovascular death in people with obesity or who are overweight.
  |
| | | | | | | | | | Join others who understand what you're going through, and discover a safe space for community, guidance, and support to manage Psoriasis symptoms together. | | | | | | Bezzy and Healthline are owned by RVO Health. | | | | | | | |
| | | | | | A pollen allergy is one of the most common causes of allergies in the United States. Discover types, prevention tips, and more. | | | | | | |
|
|
|
| | | | | Menu variety for plant-powered choices, balanced living, keto, and paleo diets. | | | | | | | |
|
|
|
| Until then, |  | Take care of yourself, and we'll
see you again soon! | | |
| View in browser
Did a friend send you this email? Subscribe here.
To see all newsletters, click here.
Privacy | Unsubscribe
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.
© 2024 Healthline Media LLC
275 7th Ave., 24th Floor
New York, NY 10001 | | |
No comments:
Post a Comment